Skip to main content
Premium Trial:

Request an Annual Quote

REPEAT: Feb 1, 2001

Premium

“The only intellectually honest position would be to not publish the [Celera] paper. If it came to me, I would simply chuck it in the bin without even opening the FedEx package.”

— Michael Ashburner, Professor of Biology, Department of Genetics, University of Cambridge, and Joint-Head, European Bioinformatics Institute

The Scan

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.